Reply: Neuropathy as a potential complication of levodopa use in Parkinson's disease: A pharmacological and pharmacovigilance point of view

Movement Disorders

Volumn 25, Issue 4, 2010, Pages 525-

  Toth, Cory ^a   Suchowersky, Oksana ^a   Zochodne, Douglas ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

DISEASE ASSOCIATION; DISEASE COURSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; LETTER; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHYSICIAN; PRIORITY JOURNAL;

ANTIPARKINSON AGENTS; HUMANS; LEVODOPA; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 77949522149     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22879     Document Type: Letter

References (12)

1. Toth C, Brown MS, Furtado S, Suchowersky O, Zochodne D. Neuropathy as a potential complication of levodopa use in Parkinson's disease. Mov Disord 2008;23:1850-1859.
2. Montastruc JL. Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view. Mov Disord 2009 [epub ahead of print].
3. Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology 1976;26:423-429.
4. Koller WC. Sensory symptoms in Parkinson's disease. Neurology 1984;34:957-959.
5. Sathian K, Zangaladze A, Green J, Vitek JL, DeLong MR. Tactile spatial acuity and roughness discrimination: impairments due to aging and Parkinson's disease. Neurology 1997;49:168-177.
6. Schneider JS, Diamond SG, Markham CH. Parkinson's disease: sensory and motor problems in arms and hands. Neurology 1987;37: 951-956.
7. Simpson DM, Kitch D, Evans SR, et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 2006;66:1679-1687.
8. Umapathi T, Tan WL, Loke SC, Soon PC, Tavintharan S, Chan YH. Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve 2007;35:591-598.
9. Derry S, Kong Loke Y, Aronson JK. Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med Res Methodol 2001;1:7.
10. Golder S, McIntosh HM, Duffy S, Glanville J. Developing efficient search strategies to identify reports of adverse effects in MEDLINE and EMBASE. Health Info Libr J 2006;23:3-12.
11. Wieland S, Dickersin K. Selective exposure reporting and medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives. J Clin Epidemiol 2005;58: 560-567.
12. Golder S, Loke Y, McIntosh HM. Poor reporting and inadequate searches were apparent in systematic reviews of adverse effects. J Clin Epidemiol 2008;61:440-448.